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in its fifth decade of existence, the construct of schizotypy 
is recapturing the early scientific interest it attracted when 
Paul E.  Meehl (1920–2003), who coined the term, pio-
neered the field of schizotypy research. the international 
lemanic Workshop on Schizotypy, hosted at the 
University of Geneva in december 2013, recently offered 
an opportunity to address some of the fundamental ques-
tions in contemporary schizotypy research and situate the 
construct in the greater scheme of future scientific proj-
ects on schizophrenia and psychological health research. 
What kind of knowledge has schizotypy research provided 
in furthering our understanding of schizophrenia? What 
types of questions can schizotypy research tackle, and 
which are the conceptual and methodological frameworks 
to address them? How will schizotypy research contribute 
to future scientific endeavors? the international lemanic 
Workshop brought together leading experts in the field 
around the tasks of articulating the essential findings in 
schizotypy research, as well as providing some key insights 
and guidance to face scientific challenges of the future. 
the current supplement contains 8 position articles, 4 
research articles, and 1 invited commentary that outline 
the state of the art in schizotypy research today.
This neural integrative defect, which I shall christen schizo-
taxia, is all that can properly be spoken of as inherited. 
The imposition of a social learning history upon schizo-
taxic individuals results in a personality organization which 
I shall call, following Rado, the schizotype
Paul Meehl, 1962 (p. 830).1
Has this been a fertile paradigm? I think the answer is abso-
lutely yes… It has really stood the test of time well.
Kenneth S. Kendler, 2013, 25th Association for 
Psychological Science Conference
“How does schizotypy really contribute to understand-
ing schizophrenia and related disorders?” Following 
the pioneering work of Paul Meehl on the construct 
of schizotypy,1 and much in the spirit of 1993’s NATO 
scientific workshop on schizotypy in Italy, scientists in 
the field recently reunited at the University of Geneva, 
Switzerland, for the International Lemanic workshop 
on schizotypy (http://lemanicworkshop.wix.com/schizo-
typy). The workshop aimed to provide an integrative 
platform addressing the very basic question of what 
schizotypy represents and how it can meaningfully con-
tribute to knowledge in the field of schizophrenia research 
and psychology.
Meehl was dedicated to investigate “the old European 
notion of  an ‘integrative neural defect’ as the only direct 
phenotypic consequence produced by the genic muta-
tion” 1(p829). Since his first report, Meehl and follow-
ers refined the construct of  schizotypy,2–5 while others 
expanded schizotypy research to the domain of  psy-
chometric personality psychology.6–8 Irrespective of 
whether one is more or less influenced by either tradi-
tion, we argue that schizotypy is the most influential, 
comprehensive psychological construct in schizophre-
nia research, inspiring contemporary concepts such as 
endophenotypes9 and at-risk mental states.10 Its theo-
retical framework remains unique in that it articulates 
different levels of  investigation, encompassing the 
nature-nurture debate, accounting for genetic, molecu-
lar, neuronal, and imaging studies, together with social, 
experimental, developmental, cognitive, and clinical 
psychological studies around a solid, multidimensional 
core of  schizotypy dimensions. In providing a frame-
work for these diverse topics, the construct of  schizotypy 
helps to secure a basis for an integrated understanding 
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of pathology and health in schizophrenia spectrum 
manifestations.
For the past 50 years, however, researchers in the clinical 
domain have mainly followed exclusive research avenues. 
Methodologies tend to either focus on the molecular, 
neurophysiological, and environmental and cultural cor-
relates of psychotic expression or investigate a variety of 
potential endophenotypes relating to schizophrenia. The 
evidence from schizotypy research is slowly yet steadily 
integrated into these fields. Indeed, as our special issue 
will outline, the evidence linking schizotypy to psychosis 
is both abundant and parceled.
This supplement provides a series of articles present-
ing the key contributions of the International Lemanic 
Workshop on Schizotypy. Specifically, the manuscripts 
bring forward the available data arguing that the schizo-
typy framework can play a decisive role in furthering the 
understanding of schizophrenia and related disorders 
but equally healthy human behavior and experience. The 
workshop was planned such that a priori major empirical 
domains were covered (assessment of schizotypy, biologi-
cal and neurocognitive dimensions of schizotypy, devel-
opment of schizotypy, and the integrative framework of 
schizotypy). The present supplement further includes 
4 original studies illustrating the novel methodologies 
and insights gained through contemporary schizotypy 
research.
The first 2 articles of  this special supplement of 
Schizophrenia Bulletin introduce the concept of  schizo-
typy and how it can be assessed. Firstly, Kwapil and 
Barrantes-Vidal11 provide a historical account on 
schizotypy research (including the debate about dimen-
sional and taxonic models) and eschew fundamen-
tal principles and misconceptions in guiding future 
research on schizotypy. In particular, the authors 
argue that schizotypy represents a unifying construct 
that efficiently links a broad continuum of  clinical 
and subclinical manifestations. Secondly, Mason12 
describes contemporary schizotypy assessment meth-
ods originating in clinical or psychometric personality 
tradition. His survey of  schizotypy measurement tools 
additionally provides a guide to their application in 
scientific research.
The following 6 position articles outline the critical 
contributions of schizotypy research to understanding 
schizophrenic spectrum disorders and health. In the first 
of these articles, Debbané and Barrantes-Vidal13 offer 
an explicit developmental model that situates schizotypy 
in the emerging domain of high-risk research and argue 
for the added value of a transactional, multidimensional 
examination of schizotypy during development. In the 
subsequent article, Debbané et  al14 provide a thorough 
review of the available prospective longitudinal studies 
examining the predictive value of schizotypy expression 
on the development of psychotic-spectrum disorders. 
Next, Barrantes-Vidal et  al15 propose a comprehensive 
overview on the etiological factors in schizotypy. The 
authors report on genetic, biological, and psychosocial 
measures that show an important overlap in schizotypy 
and schizophrenia, supporting the notion of phenom-
enological and etiological continuity in the schizophrenia 
spectrum. Yet, the authors also stress differential find-
ings between schizotypy and schizophrenia that might 
help to identify potential protective factors to consider 
for schizotypy research. In the contribution by Ettinger 
et al,16 the authors present a selective review on the cogni-
tive and cerebral functional profiles one can observe in 
individuals reporting elevated schizotypy. Findings from 
the domains of perception, attention, memory, imag-
ery and representation, language, and motor control 
show deficits that are similar, yet quantitatively milder, 
to those in patients with schizophrenia. The very fact 
that differences in schizotypy expression relate to vari-
ance in cognitive performance underlines the potential 
etiological insights that can be gained by studying sub-
clinical, trait-level schizotypy. Furthermore, the authors 
point to 2 domains in which elevated schizotypy links to 
“superior” performance, ie, enhanced vividness and bet-
ter performance on tasks of mental rotation. Mohr and 
Claridge17 further contextualize these cognitive advan-
tages. Here, the authors refer to healthy individuals with 
mainly positive psychotic-like traits (positive schizotypy, 
but also affective features mapping onto bipolar disor-
der), who may benefit from positive adaptations such as 
personal well-being, cognitive (mainly creative) abilities, 
and a favorable personality profile. The final article in 
this section by Cohen et  al18 complements the previous 
2 contributions by focusing on the social and affective 
components in schizotypy. The authors offer a concep-
tual framework within which individual differences in 
healthy affective and social functions can be understood 
in the light of schizotypy expression. The authors further 
highlight the neurodevelopmental, neurobiological, and 
psychological underpinnings of affiliative drives, hedonic 
capacity, social cognition, and stress responsivity sys-
tems. Finally, they discuss the neural compensatory and 
resilience factors as well as schizotypy’s potential role for 
understanding cultural determinants of social and affec-
tive functions.
In the final section, 4 cutting-edge studies illustrate 
recent examples of empirical schizotypy research. In the 
first study, Wang et al19 provide an illustration of integra-
tive research by combining structural neuroimaging to 
resting state functional connectivity analysis in revealing 
neurobiological changes specifically associated to schizo-
typy. Herzig et al20 used a behavioral marker (functional 
hemispheric asymmetry for language) to investigate 
whether and how cannabis use along the schizophre-
nia spectrum (first episode patients, healthy individuals 
differing in schizotypy) links to aberrant performance. 
Everett and Linscott21 present new evidence for a taxonic 
view of schizotypy through the longitudinal investigation 
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of psychiatric patients. Finally, Fonseca-Pedrero et  al22 
report on an original experimental paradigm that sug-
gests an observable association between early adolescent 
schizotypy expression and proneness to experience exper-
imentally induced visual illusions.
In conclusion, Lenzenweger23 provides an overarching 
commentary on the special issue and critically formulates 
important conceptual considerations as we envision the 
future of the field and its potential to integrate differ-
ent levels of analyses in our understanding of psychotic 
disorders.
The 2013 International Lemanic Workshop on 
Schizotypy Research set the foundations for future collab-
orative research through the creation of the Consortium 
for International Schizotypy Research. The objective of 
this consortium is to provide a platform for data shar-
ing encompassing psychometric, genetic, cognitive, and 
imaging domains. It further aims to provide new genera-
tions of scientists opportunities to integrate past insights 
to current and future scientific endeavors not only in the 
fields of schizotypy but also in schizophrenia research 
and health psychology more generally.
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